Literature DB >> 10797261

Genetic changes in breast cancer detected by comparative genomic hybridisation.

R L Loveday1, J Greenman, D L Simcox, V Speirs, P J Drew, J R Monson, M J Kerin.   

Abstract

Breast cancer is characterised by a number of genetic aberrations. Our purpose was to use comparative genomic hybridisation (CGH) to screen breast carcinomas for copy number changes: 44 ductal and 8 lobular carcinomas were studied and a large number of genetic aberrations identified. Many of these showed similarity to previous CGH results, however, a number of loci not previously shown to have undergone frequent change were identified. This included copy number gains affecting chromosomes 1p, 4q, 5q, 6q and 13q. Furthermore, we have identified 2 regions of copy number change, the gain on 5p and deletion of 16q, which correlated with lobular carcinomas. Our results highlight several areas of the genome that may be important in the molecular genetics of breast cancer. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10797261     DOI: 10.1002/(sici)1097-0215(20000515)86:4<494::aid-ijc8>3.0.co;2-o

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  19 in total

Review 1.  The molecular pathology of breast cancer progression.

Authors:  Alessandro Bombonati; Dennis C Sgroi
Journal:  J Pathol       Date:  2010-11-16       Impact factor: 7.996

Review 2.  The role of estrogen in the initiation of breast cancer.

Authors:  J Russo; Irma H Russo
Journal:  J Steroid Biochem Mol Biol       Date:  2006-12       Impact factor: 4.292

3.  Genetic determination of susceptibility to estrogen-induced mammary cancer in the ACI rat: mapping of Emca1 and Emca2 to chromosomes 5 and 18.

Authors:  Karen A Gould; Martin Tochacek; Beverly S Schaffer; Tanya M Reindl; Clare R Murrin; Cynthia M Lachel; Eric A VanderWoude; Karen L Pennington; Lisa A Flood; Kimberly K Bynote; Jane L Meza; Michael A Newton; James D Shull
Journal:  Genetics       Date:  2004-12       Impact factor: 4.562

Review 4.  Preinvasive breast cancer.

Authors:  Dennis C Sgroi
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

5.  DNA repair by homologous recombination, but not by nonhomologous end joining, is elevated in breast cancer cells.

Authors:  Zhiyong Mao; Ying Jiang; Xiang Liu; Andrei Seluanov; Vera Gorbunova
Journal:  Neoplasia       Date:  2009-07       Impact factor: 5.715

Review 6.  Estrogen, male dominance and esophageal adenocarcinoma: is there a link?

Authors:  Huiqi Yang; Olga A Sukocheva; Damian J Hussey; David I Watson
Journal:  World J Gastroenterol       Date:  2012-02-07       Impact factor: 5.742

7.  8p deletion is strongly linked to poor prognosis in breast cancer.

Authors:  P Lebok; A Mittenzwei; M Kluth; C Özden; B Taskin; K Hussein; K Möller; A Hartmann; A Lebeau; I Witzel; S Mahner; L Wölber; F Jänicke; S Geist; P Paluchowski; C Wilke; U Heilenkötter; R Simon; G Sauter; L Terracciano; R Krech; A von der Assen; V Müller; E Burandt
Journal:  Cancer Biol Ther       Date:  2015-05-11       Impact factor: 4.742

8.  New single nucleotide polymorphisms (SNPs) in homologous recombination repair genes detected by microarray analysis in Polish breast cancer patients.

Authors:  Hanna Romanowicz; Dominik Strapagiel; Marcin Słomka; Marta Sobalska-Kwapis; Ewa Kępka; Anna Siewierska-Górska; Marek Zadrożny; Jan Bieńkiewicz; Beata Smolarz
Journal:  Clin Exp Med       Date:  2016-11-30       Impact factor: 3.984

9.  Invasive lobular carcinoma with extracellular mucin production and HER-2 overexpression: a case report and further case studies.

Authors:  Jing Yu; Rohit Bhargava; David J Dabbs
Journal:  Diagn Pathol       Date:  2010-06-15       Impact factor: 2.644

10.  Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles.

Authors:  F Bertucci; B Orsetti; V Nègre; P Finetti; C Rougé; J-C Ahomadegbe; F Bibeau; M-C Mathieu; I Treilleux; J Jacquemier; L Ursule; A Martinec; Q Wang; J Bénard; A Puisieux; D Birnbaum; C Theillet
Journal:  Oncogene       Date:  2008-05-19       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.